Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-18,852
Closed -$1.74M 785
2018
Q1
$1.74M Sell
18,852
-14,520
-44% -$1.29M 0.03% 503
2017
Q4
$2.13M Buy
33,372
+1,900
+6% +$145K 0.04% 438
2017
Q3
$2.72M Buy
31,472
+3,567
+13% +$289K 0.05% 391
2017
Q2
$2.14M Hold
27,905
0.04% 450
2017
Q1
$2.06M Hold
27,905
0.04% 434
2016
Q4
$2.26M Buy
27,905
+1,528
+6% +$150K 0.05% 349
2016
Q3
$3.72M Buy
26,377
+3,057
+13% +$350K 0.09% 243
2016
Q2
$1.85M Hold
23,320
0.05% 325
2016
Q1
$1.89M Hold
23,320
0.05% 330
2015
Q4
$2.08M Hold
23,320
0.06% 291
2015
Q3
$2.11M Sell
23,320
-2,665
-10% -$395K 0.05% 332
2015
Q2
$4.4M Sell
25,985
-5,604
-18% -$795K 0.09% 256
2015
Q1
$3.18M Buy
31,589
+19,361
+158% +$1.93M 0.06% 326
2014
Q4
$953K Buy
+12,228
New +$752K 0.02% 442

Other funds holding AGEN

Candriam SCA's AGEN Position: Q2 2018 in Review

Candriam SCA sold out of Agenus (AGEN) in Q2 2018, closing a stake of 18,852 shares — an estimated $1.74M sold.

Candriam SCA first reported a position in AGEN in Q4 2014 and held it in 14 quarters. The position peaked at $4.4M in Q2 2015. 99 funds tracked by Wall St. Rank hold AGEN as of Q2 2018.

  • Candriam SCA reported no remaining Agenus position as of Q2 2018 after selling out during the quarter.
  • Candriam SCA sold 18,852 Agenus shares in Q2 2018, an estimated $1.74M.
  • Candriam SCA first reported a position in Agenus in Q4 2014 and held it in 14 quarters.
  • Candriam SCA's Agenus position peaked at $4.4M in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Agenus as of Q2 2018.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.